Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sara Shalin

Concepts (428)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Skin Neoplasms
33
2024
492
8.870
Why?
Skin Diseases
7
2022
111
4.130
Why?
Melanoma
16
2024
290
3.970
Why?
Dermatology
9
2024
49
3.410
Why?
Skin
12
2024
415
3.230
Why?
Sebaceous Gland Neoplasms
5
2022
16
1.860
Why?
Carcinoma, Basal Cell
5
2018
37
1.810
Why?
Immunohistochemistry
17
2021
978
1.790
Why?
Staining and Labeling
3
2021
97
1.650
Why?
Adenocarcinoma, Sebaceous
3
2022
7
1.610
Why?
Biopsy
18
2024
590
1.610
Why?
Nevus, Blue
2
2021
12
1.410
Why?
Melanocytes
3
2021
38
1.400
Why?
Humans
83
2024
50208
1.360
Why?
Neoplasms, Second Primary
2
2024
78
1.300
Why?
Dermatitis
2
2022
36
1.290
Why?
Erythema Multiforme
2
2020
11
1.220
Why?
Female
46
2024
26635
1.220
Why?
Aged, 80 and over
18
2024
3154
1.110
Why?
Vulvar Neoplasms
3
2022
52
1.100
Why?
Vasculitis
2
2024
29
1.090
Why?
Middle Aged
31
2024
12206
1.060
Why?
Nevus, Pigmented
2
2016
35
1.030
Why?
Alopecia
2
2024
39
1.030
Why?
Herpes Simplex
2
2022
21
1.020
Why?
Sebaceous Glands
2
2024
14
0.980
Why?
Skin Diseases, Vascular
1
2024
8
0.970
Why?
Incidental Findings
1
2024
39
0.950
Why?
Neoplasm Staging
2
2024
738
0.950
Why?
Dermatitis, Seborrheic
1
2024
4
0.950
Why?
Sweat Gland Neoplasms
3
2024
22
0.950
Why?
Diagnosis, Differential
13
2024
1043
0.940
Why?
Atrophy
1
2024
38
0.940
Why?
Sentinel Lymph Node Biopsy
1
2024
117
0.910
Why?
Nevus, Epithelioid and Spindle Cell
3
2018
15
0.890
Why?
Aged
26
2024
9405
0.890
Why?
Papillomavirus Infections
2
2022
155
0.890
Why?
Hyperoxaluria
1
2022
5
0.860
Why?
Hyperoxaluria, Primary
1
2022
4
0.860
Why?
Urolithiasis
1
2022
5
0.860
Why?
Graft vs Host Disease
2
2020
75
0.860
Why?
Adenoma
2
2017
110
0.840
Why?
Pathology
2
2020
33
0.840
Why?
Epidermal Cyst
1
2022
12
0.830
Why?
Granuloma
2
2020
44
0.820
Why?
Adult
23
2024
13324
0.820
Why?
Carcinoma in Situ
1
2022
72
0.810
Why?
Protein Kinases
2
2016
71
0.800
Why?
Muscle, Smooth
1
2021
64
0.790
Why?
Fungi
1
2021
44
0.770
Why?
Elastic Tissue
2
2020
10
0.760
Why?
Artifacts
1
2021
54
0.760
Why?
Epidermodysplasia Verruciformis
1
2020
2
0.760
Why?
Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit
1
2020
2
0.750
Why?
Foreign Bodies
1
2021
65
0.750
Why?
Histiocytoma, Benign Fibrous
1
2020
14
0.740
Why?
Methenamine
1
2020
1
0.740
Why?
Periodic Acid-Schiff Reaction
1
2020
2
0.740
Why?
Lichenoid Eruptions
1
2020
3
0.740
Why?
Oncogene Proteins, Fusion
2
2020
58
0.740
Why?
Vulvar Diseases
1
2020
7
0.730
Why?
Kidney Failure, Chronic
1
2022
200
0.730
Why?
Genitalia
1
2020
11
0.720
Why?
Uterine Cervical Dysplasia
1
2020
49
0.720
Why?
Lichen Sclerosus et Atrophicus
1
2020
7
0.720
Why?
Lymphatic Metastasis
2
2020
227
0.710
Why?
Syphilis
1
2020
27
0.710
Why?
Gynecology
1
2020
49
0.700
Why?
Lupus Erythematosus, Systemic
1
2020
69
0.700
Why?
Male
31
2024
25399
0.690
Why?
Pseudoxanthoma Elasticum
1
2019
4
0.680
Why?
Pathology, Surgical
1
2019
18
0.670
Why?
Fibroma
2
2020
39
0.640
Why?
Pathology, Clinical
4
2021
24
0.640
Why?
Telangiectasis
1
2018
3
0.630
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.620
Why?
Carcinoma, Squamous Cell
2
2024
318
0.620
Why?
Carcinoma, Large Cell
1
2017
15
0.600
Why?
Carcinoma, Neuroendocrine
1
2017
24
0.600
Why?
Neoplasms, Multiple Primary
1
2018
44
0.600
Why?
Laryngeal Neoplasms
1
2017
42
0.590
Why?
Hidrocystoma
1
2017
5
0.590
Why?
Apocrine Glands
1
2017
7
0.590
Why?
Calcium Oxalate
1
2017
8
0.590
Why?
Inflammation
2
2020
604
0.580
Why?
Young Adult
10
2024
3981
0.570
Why?
Tumor Suppressor Protein p53
3
2020
203
0.550
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2016
55
0.530
Why?
Brain Neoplasms
2
2020
288
0.520
Why?
Transcription Factors
2
2021
564
0.520
Why?
Carcinoma, Merkel Cell
2
2022
41
0.520
Why?
Sarcoptes scabiei
1
2015
2
0.510
Why?
Scabies
1
2015
4
0.510
Why?
Genital Diseases, Male
1
2015
17
0.500
Why?
Lymphangioma
1
2014
9
0.500
Why?
Histiocytosis, Sinus
1
2015
14
0.490
Why?
Scrotum
1
2015
30
0.490
Why?
Arm
1
2014
47
0.460
Why?
Acanthoma
1
2013
2
0.460
Why?
Fibroadenoma
1
2013
7
0.460
Why?
Eccrine Glands
1
2013
11
0.460
Why?
Nuclear Proteins
1
2014
243
0.430
Why?
Leuprolide
1
2012
2
0.420
Why?
Mucinosis, Follicular
1
2012
3
0.420
Why?
Drug Eruptions
1
2012
13
0.420
Why?
Endometriosis
1
2012
14
0.420
Why?
Cicatrix
1
2012
40
0.410
Why?
Mycosis Fungoides
1
2012
28
0.410
Why?
Adenocarcinoma, Clear Cell
1
2012
34
0.410
Why?
Antineoplastic Agents, Hormonal
1
2012
48
0.410
Why?
Thrombosis
1
2015
248
0.400
Why?
Social Media
3
2018
96
0.390
Why?
Dermis
2
2021
18
0.380
Why?
Histones
3
2020
313
0.370
Why?
Cesarean Section
1
2012
187
0.370
Why?
Vulva
2
2020
17
0.370
Why?
Mucous Membrane
2
2020
28
0.360
Why?
Muir-Torre Syndrome
1
2010
1
0.350
Why?
Hippocampus
3
2006
228
0.340
Why?
Gene Rearrangement
2
2021
74
0.340
Why?
Adolescent
7
2022
6390
0.320
Why?
Mutation
4
2024
1294
0.310
Why?
Epithelioid Cells
2
2020
13
0.310
Why?
Up-Regulation
3
2020
453
0.300
Why?
Dermatomycoses
2
2016
19
0.280
Why?
Leukemia, Myeloid, Acute
3
2016
185
0.280
Why?
Factor XIIIa
2
2016
10
0.270
Why?
Mutation, Missense
3
2020
105
0.270
Why?
Neuronal Plasticity
1
2006
56
0.260
Why?
MAP Kinase Signaling System
1
2006
118
0.260
Why?
Antifungal Agents
3
2016
339
0.260
Why?
Memory
1
2006
117
0.260
Why?
Memory Disorders
1
2006
54
0.260
Why?
Postoperative Complications
1
2012
996
0.260
Why?
Signal Transduction
2
2016
1622
0.250
Why?
Fluorescent Antibody Technique, Direct
1
2024
3
0.250
Why?
Neurons
2
2006
460
0.230
Why?
SOXE Transcription Factors
2
2021
4
0.230
Why?
MART-1 Antigen
2
2021
12
0.230
Why?
Hematopoietic Stem Cell Transplantation
3
2019
567
0.230
Why?
Mitogen-Activated Protein Kinase 1
1
2004
50
0.230
Why?
Sensitivity and Specificity
2
2024
863
0.230
Why?
Chickenpox
1
2024
18
0.230
Why?
Nevus
1
2024
17
0.230
Why?
Lymphoma
1
2024
66
0.230
Why?
Fear
1
2004
83
0.220
Why?
Carcinoma
1
2024
139
0.220
Why?
Disease Outbreaks
1
2024
125
0.220
Why?
Oxalates
1
2022
12
0.210
Why?
Angioedema
1
2022
9
0.210
Why?
Demography
1
2022
92
0.210
Why?
Sarcoidosis
1
2022
44
0.200
Why?
Rhabdomyosarcoma, Alveolar
1
2022
8
0.200
Why?
Foot
1
2022
42
0.200
Why?
Prednisone
1
2022
101
0.200
Why?
Plant Structures
1
2021
5
0.200
Why?
Cotton Fiber
1
2021
6
0.200
Why?
Paper
1
2021
15
0.200
Why?
Herpesvirus 2, Human
1
2021
5
0.200
Why?
Lymphokines
1
2021
20
0.200
Why?
Herpesvirus 1, Human
1
2021
15
0.200
Why?
Platelet-Derived Growth Factor
1
2021
23
0.200
Why?
Histocytochemistry
1
2021
47
0.200
Why?
Dermatofibrosarcoma
1
2021
8
0.200
Why?
Herpesvirus 3, Human
1
2021
29
0.200
Why?
Hyperplasia
1
2021
96
0.200
Why?
Sutures
1
2021
40
0.190
Why?
Coloring Agents
1
2021
70
0.190
Why?
Stromal Cells
1
2021
72
0.190
Why?
Animals
10
2021
13246
0.190
Why?
Cadherins
2
2019
68
0.190
Why?
Retrospective Studies
4
2024
6134
0.190
Why?
Protein Processing, Post-Translational
2
2020
171
0.190
Why?
Lost to Follow-Up
1
2020
10
0.190
Why?
Chromones
1
2021
20
0.190
Why?
Oncogene Fusion
1
2020
4
0.190
Why?
Gene Expression Regulation, Neoplastic
3
2020
828
0.190
Why?
Research Report
1
2020
16
0.190
Why?
Leprosy, Multibacillary
1
2020
5
0.190
Why?
Armadillos
1
2020
6
0.190
Why?
DNA-Activated Protein Kinase
1
2021
26
0.180
Why?
S100 Proteins
2
2021
34
0.180
Why?
Skin Transplantation
1
2021
44
0.180
Why?
Morpholines
1
2021
70
0.180
Why?
Histiocytes
1
2020
10
0.180
Why?
Neoplasms, Fibrous Tissue
1
2020
2
0.180
Why?
Phagocytosis
1
2020
49
0.180
Why?
Graft Survival
1
2021
150
0.180
Why?
Germ Cells
1
2020
12
0.180
Why?
Ubiquitin-Protein Ligases
1
2021
95
0.180
Why?
Papillomaviridae
1
2020
102
0.180
Why?
Lymphocytes, Tumor-Infiltrating
2
2018
78
0.180
Why?
Matrix Metalloproteinase 2
1
2020
57
0.180
Why?
Single-Cell Analysis
1
2020
61
0.180
Why?
Li-Fraumeni Syndrome
1
2020
13
0.180
Why?
Immunotherapy
2
2019
240
0.180
Why?
Matrix Metalloproteinase 9
1
2020
89
0.180
Why?
Graft Rejection
1
2021
168
0.170
Why?
Adenocarcinoma
1
2024
397
0.170
Why?
Consensus
1
2020
150
0.170
Why?
Proto-Oncogene Proteins B-raf
2
2017
79
0.170
Why?
Elastin
1
2019
23
0.170
Why?
Intracranial Arteriovenous Malformations
1
2019
29
0.160
Why?
Integrin alpha Chains
1
2019
11
0.160
Why?
Disease Progression
3
2020
831
0.160
Why?
Cell Cycle Checkpoints
1
2019
32
0.160
Why?
Child
4
2022
6851
0.160
Why?
Melanoma, Experimental
1
2019
45
0.160
Why?
Arteriovenous Malformations
1
2019
66
0.150
Why?
DNA-Binding Proteins
1
2021
428
0.150
Why?
Acute Disease
1
2019
368
0.150
Why?
Collagen
1
2019
207
0.150
Why?
Cricoid Cartilage
1
2017
11
0.150
Why?
Proto-Oncogene Proteins c-kit
1
2017
36
0.150
Why?
Dilatation
1
2017
26
0.150
Why?
Antigens, CD
1
2019
221
0.150
Why?
Practice Guidelines as Topic
1
2020
449
0.150
Why?
T-Lymphocytes, Regulatory
1
2018
86
0.150
Why?
Tumor Burden
1
2017
131
0.150
Why?
Connective Tissue Diseases
1
2017
16
0.150
Why?
Tumor Escape
1
2017
16
0.150
Why?
Parvoviridae Infections
1
2017
20
0.150
Why?
Immunologic Surveillance
1
2017
10
0.150
Why?
Parvovirus B19, Human
1
2017
17
0.150
Why?
CTLA-4 Antigen
1
2017
25
0.140
Why?
Rhizopus
1
2016
4
0.140
Why?
Histone Code
1
2017
32
0.140
Why?
Trachea
1
2017
52
0.140
Why?
Sarcoma
1
2018
67
0.140
Why?
Programmed Cell Death 1 Receptor
1
2017
39
0.140
Why?
RNA, Fungal
1
2016
21
0.140
Why?
Mucormycosis
1
2016
29
0.140
Why?
Connexins
1
2016
25
0.140
Why?
Splenomegaly
1
2016
10
0.140
Why?
Ascomycota
1
2016
9
0.140
Why?
Angiomyoma
1
2016
5
0.140
Why?
Infant
2
2015
3563
0.140
Why?
Antineoplastic Agents, Alkylating
1
2016
74
0.140
Why?
Osteosarcoma
1
2016
47
0.130
Why?
Mice
6
2021
5759
0.130
Why?
Apoptosis
3
2019
1112
0.130
Why?
Recurrence
2
2015
662
0.130
Why?
Human Growth Hormone
1
2016
50
0.130
Why?
Candidiasis
1
2016
114
0.130
Why?
Education, Medical, Continuing
1
2016
68
0.130
Why?
Lung Neoplasms
2
2019
605
0.130
Why?
Cell Transformation, Neoplastic
1
2016
179
0.130
Why?
Dendritic Cells
1
2016
133
0.130
Why?
Adipocytes
1
2016
121
0.130
Why?
Avoidance Learning
2
2006
17
0.130
Why?
Hamartoma Syndrome, Multiple
1
2015
15
0.130
Why?
Fibrin
1
2015
10
0.130
Why?
Neoplastic Syndromes, Hereditary
1
2015
16
0.130
Why?
Facial Neoplasms
1
2015
22
0.130
Why?
WT1 Proteins
1
2014
4
0.120
Why?
Lysine
1
2015
89
0.120
Why?
Pigmentation Disorders
1
2014
5
0.120
Why?
Osteomyelitis
1
2016
126
0.120
Why?
Carcinosarcoma
1
2015
18
0.120
Why?
Purpura
1
2014
7
0.120
Why?
Keratin-20
1
2014
7
0.120
Why?
Hemangiosarcoma
1
2014
16
0.120
Why?
Fellowships and Scholarships
1
2016
111
0.120
Why?
United States
2
2022
4874
0.120
Why?
Herpes Zoster
1
2014
14
0.120
Why?
Drug Resistance, Neoplasm
1
2017
314
0.120
Why?
Eosinophils
1
2015
39
0.120
Why?
Loss of Heterozygosity
1
2015
77
0.120
Why?
Patient Education as Topic
1
2018
313
0.120
Why?
Churg-Strauss Syndrome
1
2014
3
0.120
Why?
Prospective Studies
1
2020
2379
0.120
Why?
Tumor Suppressor Proteins
1
2015
128
0.120
Why?
DNA Copy Number Variations
1
2015
110
0.120
Why?
Antigens, CD34
1
2014
66
0.120
Why?
Mass Spectrometry
1
2015
301
0.120
Why?
Lymphocytes
1
2015
154
0.120
Why?
Exanthema
1
2014
32
0.120
Why?
Neoplasm Proteins
1
2016
324
0.110
Why?
Neutrophils
1
2015
148
0.110
Why?
Eosinophilia
1
2014
37
0.110
Why?
Sarcoma, Kaposi
1
2014
72
0.110
Why?
Membrane Glycoproteins
1
2014
246
0.110
Why?
Head and Neck Neoplasms
1
2016
273
0.110
Why?
Chromosome Aberrations
1
2015
297
0.110
Why?
Antibodies, Monoclonal
1
2017
460
0.110
Why?
Kaplan-Meier Estimate
3
2020
465
0.110
Why?
Prognosis
4
2019
1954
0.100
Why?
Proteasome Endopeptidase Complex
1
2013
117
0.100
Why?
DNA Mismatch Repair
1
2012
16
0.100
Why?
Treatment Outcome
5
2021
5155
0.100
Why?
Predictive Value of Tests
1
2014
905
0.100
Why?
Cell Differentiation
1
2014
650
0.100
Why?
Multiple Myeloma
2
2016
2954
0.100
Why?
Asthma
1
2014
280
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
595
0.080
Why?
Fatal Outcome
2
2022
195
0.080
Why?
CD8-Positive T-Lymphocytes
2
2019
128
0.070
Why?
Phorbol Esters
1
2006
3
0.070
Why?
Association Learning
1
2006
11
0.070
Why?
Theta Rhythm
1
2006
10
0.070
Why?
Amphotericin B
2
2016
110
0.070
Why?
Child, Preschool
1
2015
3883
0.070
Why?
Maze Learning
1
2006
32
0.070
Why?
Mice, Mutant Strains
1
2006
71
0.070
Why?
Isoproterenol
1
2006
56
0.070
Why?
Adrenergic beta-Agonists
1
2006
40
0.070
Why?
Protein Kinase C
1
2006
71
0.070
Why?
Extracellular Signal-Regulated MAP Kinases
1
2006
83
0.070
Why?
Immunocompromised Host
2
2016
119
0.070
Why?
Neoplasm Metastasis
2
2016
236
0.060
Why?
Cell Proliferation
2
2019
1013
0.060
Why?
T-Lymphocytes
2
2017
339
0.060
Why?
Nerve Growth Factor
1
2004
12
0.060
Why?
Superior Cervical Ganglion
1
2004
7
0.060
Why?
Time Factors
2
2016
2922
0.060
Why?
Disease Notification
1
2024
10
0.060
Why?
Sensory Thresholds
1
2004
17
0.060
Why?
Blotting, Southern
1
2004
42
0.060
Why?
Intellectual Disability
1
2006
124
0.060
Why?
Exploratory Behavior
1
2004
23
0.060
Why?
Mitogen-Activated Protein Kinase 3
1
2004
49
0.060
Why?
Luminescent Proteins
1
2004
55
0.060
Why?
Green Fluorescent Proteins
1
2004
91
0.060
Why?
Shock
1
2004
35
0.060
Why?
Proto-Oncogene Proteins p21(ras)
1
2024
66
0.060
Why?
Physician's Role
1
2024
47
0.060
Why?
Mitogen-Activated Protein Kinases
1
2004
155
0.060
Why?
Brain
2
2019
1328
0.060
Why?
Psychomotor Performance
1
2004
130
0.060
Why?
Animals, Newborn
1
2004
368
0.050
Why?
Behavior, Animal
1
2004
180
0.050
Why?
Motor Activity
1
2004
229
0.050
Why?
Eyelids
1
2022
29
0.050
Why?
Blotting, Western
1
2004
601
0.050
Why?
Mice, Transgenic
1
2004
550
0.050
Why?
Desmin
1
2022
6
0.050
Why?
Follow-Up Studies
2
2020
2190
0.050
Why?
Edema
1
2022
69
0.050
Why?
Gene Expression
1
2004
609
0.050
Why?
gp100 Melanoma Antigen
1
2021
9
0.050
Why?
Microphthalmia-Associated Transcription Factor
1
2021
4
0.050
Why?
DNA, Viral
1
2021
134
0.050
Why?
Mycobacterium leprae
1
2020
8
0.050
Why?
Soil Microbiology
1
2020
18
0.050
Why?
In Situ Hybridization, Fluorescence
1
2021
259
0.050
Why?
RNA, Messenger
1
2004
1108
0.050
Why?
Societies, Medical
1
2021
177
0.050
Why?
Retinoblastoma Protein
1
2020
19
0.040
Why?
Dose-Response Relationship, Drug
1
2004
1378
0.040
Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2020
16
0.040
Why?
Mice, Inbred BALB C
1
2021
305
0.040
Why?
Evidence-Based Medicine
1
2021
247
0.040
Why?
Cells, Cultured
1
2004
1581
0.040
Why?
Ulcer
1
2020
22
0.040
Why?
Radiotherapy, Adjuvant
1
2020
61
0.040
Why?
Host-Pathogen Interactions
1
2021
135
0.040
Why?
Rats, Sprague-Dawley
1
2004
1586
0.040
Why?
Antiviral Agents
1
2021
173
0.040
Why?
Germ-Line Mutation
1
2020
61
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2020
55
0.040
Why?
Malpractice
1
2019
15
0.040
Why?
Linear Models
1
2020
278
0.040
Why?
Microcirculation
1
2019
71
0.040
Why?
Diagnostic Errors
1
2019
63
0.040
Why?
Proportional Hazards Models
1
2020
410
0.040
Why?
Multivariate Analysis
1
2020
581
0.040
Why?
Fibrosis
1
2019
180
0.040
Why?
Survival Analysis
1
2020
666
0.040
Why?
Flow Cytometry
1
2021
476
0.040
Why?
Tumor Cells, Cultured
1
2019
468
0.040
Why?
Transcriptome
1
2020
320
0.040
Why?
Rare Diseases
1
2018
44
0.040
Why?
Larynx
1
2017
30
0.040
Why?
Rats
1
2004
3299
0.040
Why?
Cadaver
1
2017
97
0.040
Why?
Pressure
1
2017
106
0.040
Why?
Forkhead Transcription Factors
1
2018
112
0.040
Why?
Immunomodulation
1
2017
37
0.040
Why?
Tumor Microenvironment
1
2019
233
0.040
Why?
Forearm
1
2016
32
0.040
Why?
Genetic Predisposition to Disease
1
2020
509
0.040
Why?
Epithelial-Mesenchymal Transition
1
2017
48
0.040
Why?
Debridement
1
2016
45
0.040
Why?
Pilot Projects
1
2019
697
0.030
Why?
Blood Cell Count
1
2016
38
0.030
Why?
Toes
1
2016
14
0.030
Why?
Induction Chemotherapy
1
2016
60
0.030
Why?
Disease-Free Survival
1
2017
454
0.030
Why?
Family
1
2018
174
0.030
Why?
Lymphocyte Activation
1
2017
172
0.030
Why?
Antibiotic Prophylaxis
1
2016
61
0.030
Why?
Treatment Refusal
1
2016
37
0.030
Why?
Chemotherapy, Adjuvant
1
2016
120
0.030
Why?
Abscess
1
2016
41
0.030
Why?
Triazoles
1
2016
109
0.030
Why?
Cell Movement
1
2017
249
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2016
181
0.030
Why?
Biopsy, Needle
1
2016
181
0.030
Why?
Core Binding Factor Alpha 1 Subunit
1
2015
44
0.030
Why?
Epigenomics
1
2016
68
0.030
Why?
Disease Models, Animal
1
2021
1458
0.030
Why?
Methylation
1
2015
123
0.030
Why?
Polymerase Chain Reaction
1
2016
454
0.030
Why?
Mice, Inbred C57BL
1
2021
1819
0.030
Why?
Proteome
1
2017
173
0.030
Why?
Pedigree
1
2015
125
0.030
Why?
Comparative Genomic Hybridization
1
2015
47
0.030
Why?
Scalp
1
2015
40
0.030
Why?
Hyperlipidemias
1
2014
50
0.030
Why?
Transplantation, Autologous
1
2016
469
0.030
Why?
Arkansas
1
2020
1985
0.030
Why?
DNA Mutational Analysis
1
2015
176
0.030
Why?
Bone Marrow
1
2016
363
0.030
Why?
Respiratory Function Tests
1
2014
90
0.030
Why?
Reoperation
1
2016
454
0.030
Why?
Lipodystrophy
1
2013
9
0.030
Why?
Heterozygote
1
2013
81
0.030
Why?
Incidence
1
2016
1006
0.030
Why?
Muscular Atrophy
1
2013
70
0.030
Why?
Syndrome
1
2013
238
0.030
Why?
Neoplasm Recurrence, Local
1
2016
613
0.030
Why?
Epigenesis, Genetic
1
2015
378
0.030
Why?
Risk Assessment
1
2016
1262
0.020
Why?
Cell Line, Tumor
1
2015
1416
0.020
Why?
Severity of Illness Index
1
2014
951
0.020
Why?
Magnetic Resonance Imaging
1
2016
1541
0.020
Why?
Tomography, X-Ray Computed
1
2014
1161
0.020
Why?
Antineoplastic Agents
1
2016
1186
0.020
Why?
Shalin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Same Department Expand Description